Related Experiment Video
Updated: Jul 18, 2026

11:25
Multi-step Preparation Technique to Recover Multiple Metabolite Compound Classes for In-depth and Informative Metabolomic Analysis
Published on: July 11, 2014
Development of validated stereoselective methods for methadone determination in clinical samples.
S Rudaz1, D Ortelli, M Gex-Fabry
1Laboratory of Pharmaceutical Analytical Chemistry, University of Geneva, Switzerland.
Chirality
|July 27, 1999
Summary
Stereoselective analysis of methadone (Mtd) in heroin-addicted patients reveals significant interindividual variability. Determining Mtd enantiomers is crucial for optimizing heroin addiction treatment.
Area of Science:
- Pharmacology
- Analytical Chemistry
- Clinical Toxicology
Background:
- Methadone (Mtd) is a key medication for treating opioid use disorder.
- Understanding Mtd pharmacokinetics, including stereoselective metabolism, is vital for effective treatment.
- Variability in Mtd levels can impact treatment efficacy and patient outcomes.
Purpose of the Study:
- To develop and validate a stereoselective analytical method for methadone in biological matrices.
- To investigate the relationship between administered methadone dose and its enantiomeric concentrations in patients.
- To assess the necessity of stereoselective methadone determination for improving heroin addiction treatment.
Main Methods:
- Development of a stereoselective liquid chromatography method using a chiral stationary phase.
- Comparison of liquid-liquid extraction (LLE) and solid-phase extraction (SPE) for sample preparation.
- Validation of the chosen method (serum matrix, LLE) and application to clinical samples from 45 heroin-addicted patients.
Main Results:
- Serum LLE provided superior extraction yield and assay precision compared to other methods.
- A correlation was observed between Mtd dose and total/R-Mtd concentrations, but significant interindividual variability in normalized Mtd levels was noted (90-530 ng/ml).
- Two patient populations with distinct mean Mtd concentrations (200 and 475 ng/ml) were identified. Over 50% showed nonracemic ratios, with ~25% exhibiting preferential metabolism of the active R-Mtd enantiomer.
Conclusions:
- Stereoselective determination of methadone is essential for personalized heroin addiction treatment.
- The developed analytical method allows for precise quantification of Mtd enantiomers in clinical samples.
- Understanding individual Mtd metabolism patterns can lead to improved therapeutic strategies and outcomes.
Related Concept Videos
Drug Concentrations: Measurements
Drug concentration is the quantity of a drug present in a biological sample. Measuring drug amounts in biological samples allows the clinician to understand how a drug is absorbed, distributed, metabolized, and excreted. Samples can be obtained through invasive or non-invasive methods. Invasive techniques involve surgical or parenteral interventions to gather blood, cerebrospinal fluid, or tissue biopsy. Conversely, non-invasive approaches provide samples like urine, feces, and saliva.
Plasma —...
Plasma —...
Phase II Reactions: Methylation Reactions
Methylation is a phase II biotransformation process involving the attachment of a methyl group to a substrate. Enzymes known as methyltransferases orchestrate this reaction.
The mechanism of methylation unfolds in two stages. The first stage sees a methyltransferase enzyme facilitating the transfer of a methyl group from S-adenosylmethionine (SAM) to the substrate, forming S-adenosylhomocysteine (SAH). The second stage involves further metabolism of SAH into homocysteine, which can be recycled...
The mechanism of methylation unfolds in two stages. The first stage sees a methyltransferase enzyme facilitating the transfer of a methyl group from S-adenosylmethionine (SAM) to the substrate, forming S-adenosylhomocysteine (SAH). The second stage involves further metabolism of SAH into homocysteine, which can be recycled...
Therapeutic Drug Monitoring: Drug Analysis Methods
Therapeutic Drug Monitoring (TDM) is a clinical practice that measures specific drug levels in a patient's blood or body tissues to tailor drug therapy effectively. This monitoring is critical for managing drugs with narrow therapeutic indices like digoxin and phenytoin, ensuring they are both safe and effective. For instance, monitoring theophylline levels in asthma patients involves precision and sensitivity to adjust doses according to individual responses to therapy, ensuring efficacy and...

